MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    The application of mobile health technology to increase physical activity in persons with Parkinson’s disease

    T.D. Ellis, T.R. DeAngelis, K. Hendron, J.T. Cavanaugh, N. Sullivan, L. Goehring, C.A. Thomas, M. Saint-Hilaire, N.K. Latham (Boston, MA, USA)

    Objective: To investigate the safety, acceptability and preliminary evidence of efficacy of a mobile health (mhealth) mediated home-based exercise program to increase physical activity in…
  • 2016 International Congress

    Biseptol a new antiParkinsonian agent?

    K. Karpinska, V. Smolanka (Uzhgorod, Ukraine)

    Objective: To evaluate the possible effect of combined intake of levodopa/carbidopa and trimethoprim/sulfamethoxazole on the duration of ON/OFF periods in a PD patient. Background: Drug…
  • 2016 International Congress

    When is the worst period of nocturnal hypokinesia in Parkinson’s disease? A sensor-based analysis

    J. Sringean, P. Taechalertpaisarn, C. Thanawattano, R. Bhidayasiri (Nonthaburi, Thailand)

    Objective: To quantify the number of turning in bed throughout the night as a determinant of the severity of nocturnal hypokinesia. Background: Nocturnal hypokinesia or…
  • 2016 International Congress

    Levodopa, placebo and rotigotine change biomarker levels for oxidative stress

    S. Muhlack, M. Kinkel, L. Herrmann, L. Tönges, T. Müller (Bochum, Germany)

    Objective: The objective was to investigate the influence of the D1 receptor agonists levodopa and rotigotine compared with placebo on homocysteine and cysteinyl-glycine in plasma…
  • 2016 International Congress

    Combined stimulation of STN and SNr for resistant freezing of gait in Parkinson’s disease (STN+SNr) – A multicenter randomized controlled trial

    D. Weiss, G. Naros, C. Meisner, R. Krüger, A. Gharabaghi (Tübingen, Germany)

    Objective: 54 patients with idiopathic Parkinson's disease and freezing of gait resistant to subthalamic nucleus stimulation and dopaminergic medication will be included into this German-wide…
  • 2016 International Congress

    Strategies to improve drug development efficiency through regulatory interactions, minimizing the placebo effect and improving data integrity within a phase 3 study of tozadenant in Parkinson’s disease patients with motor fluctuations (TOZ-PD)

    F. Kerwood, C. Kenney, K. Kieburtz, W. Olanow, C. Resburg, J. Krishnaswami, S. Bandak (San Francisco, CA, USA)

    Objective: To identify and implement strategies to improve the efficiency of drug development in Phase 3 studies. Background: Conducting global clinical trials can be challenging,…
  • 2016 International Congress

    A multi-site survey of Parkinson’s disease deep brain stimulation center best practice: moving toward a standard of care for DBS

    A.A. Butala, K.A. Mills, P. Schmidt, M.S. Okun, Z. Mari (Baltimore, MD, USA)

    Objective: To survey how Deep Brain Stimulation (DBS) Centers handle referrals and peri-operative (surgical and non-surgical) treatment of persons with Parkinson's disease (PD). Background: Currently…
  • 2016 International Congress

    Spinal cord stimulation improves freezing of gait in Parkinson’s disease in chronic implanted stn-dbs patients: A case report

    C.O. Souza, C.P. Souza, A.L. Pardini, D. Boari, L.A. Teixeira, E.R. Barbosa, E.T. Fonoff (Sao Paulo, Brazil)

    Objective: The aim of our study was to evaluate further the potential role of spinal cord stimulation (SCS) as a treatment for gait disturbances and…
  • 2016 International Congress

    Can a leopard changes its spots? How impulse control disorder affects subthalamic stimulation paradigm

    N.G. Pozzi, B. Minafra, M. Picascia, R. Zangaglia, D. Servello, C. Pacchetti (Pavia, Italy)

    Objective: To study the effect of previous impulse control disorders (ICD) on subthalamic nucleus deep brain stimulation (STN-DBS) programming in subjects with Parkinson's disease (PD).…
  • 2016 International Congress

    Impact of the combined depletion of monoamines on the effectiveness of deep brain stimulation of the subthalamic nucleus

    A. Benazzouz, C. Delaville, E. Faggiani (Bordeaux, France)

    Objective: To investigate the involvement of combined depletions of dopamine, norepinephrine and serotonin in the manifestation of motor and non-motor deficits and their impact on…
  • « Previous Page
  • 1
  • …
  • 63
  • 64
  • 65
  • 66
  • 67
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • Effect of marijuana on Essential Tremor: A case report
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley